CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 5,051		$ (9,634)	$ (9,638)
Adjustments to reconcile net loss to net cash provided by operating activities:
Provision for credit losses	3,350		27,784	27,745
Depreciation and amortization	2,312		2,392	2,648
Discount accretion on debt securities	(60)		(43)	(70)
Stock-based compensation expense	87	[1]	78	209
Excess tax benefit from stock-based arrangements	0		(26)	(106)
Deferred income tax expense (benefit)	2,836		(6,132)	(4,768)
Gains on sales of investment securities	(23)		(913)	(278)
Losses (gains) on disposals of premises and equipment	82		0	(192)
Losses on sales and write-downs of other real estate owned	687		1,669	2,015
Gain on sale of wholesale insurance subsidiary	(114)		0	0
Loss on termination of cash flow hedge	0		1,306	1,339
Net changes in:
Accrued interest receivable	(102)		235	1,137
Other assets	170		4,703	1,351
Accrued interest payable	(53)		(114)	(230)
Other liabilities	(1,044)		(1,458)	224
Net cash provided by operating activities	13,179		19,847	21,386
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from maturities and principal payments of investment securities available for sale	43,418		38,512	47,854
Proceeds from sales of investment securities available for sale	988		40,351	6,275
Proceeds from sales of investment securities held to maturity	113		0	0
Purchases of investment securities available for sale	(133,006)		(87,243)	(69,491)
Proceeds from maturities and principal payments of investment securities held to maturity	443		439	3,810
Net change in loans	(3,982)		12,957	23,896
Proceeds from sale of loans	0		20,565	0
Purchases of premises and equipment	(2,077)		(545)	(2,202)
Proceeds from sales of premises and equipment	0		4	317
Proceeds from sales of other real estate owned	1,697		5,325	5,742
Proceeds from sale of subsidiary	2,878		0	0
Return of investment (investment in) unconsolidated subsidiary	0		85	0
Net cash (used in) provided by investing activities	(89,528)		30,450	16,201
CASH FLOWS FROM FINANCING ACTIVITIES:
Noninterest-bearing deposits	21,017		18,805	20,191
Interest-bearing deposits	(5,482)		(134,610)	19,163
Short-term borrowings	(5,332)		(3,621)	(4,056)
Proceeds from issuance of common stock	31,279		0	0
Excess tax benefit from stock-based arrangements	0		26	106
Repayment of long-term debt	0		0	(455)
Common stock dividends paid	0		0	(85)
Net cash provided by (used in) financing activities	41,482		(119,400)	34,864
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(34,867)		(69,103)	72,451
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	131,090		200,193	127,742
CASH AND CASH EQUIVALENTS AT END OF YEAR	96,223		131,090	200,193
Supplemental cash flow information:
Interest paid	4,300		6,589	10,792
Income taxes paid	243		265	163
Transfers from loans to other real estate owned	2,295		3,071	6,031
Transfers from loans to loans held for sale	0		23,635	0
Transfers from loans held for sale to loans	$ 3,521		$ 0	$ 0

[1] On January 7, 2015 restricted stock and options were granted to executive officers in the amount of $62 thousand in restricted stock awards and $117 thousand in option awards. The restricted stock and options immediately vested 50% on the grant date of January 7, 2015, in which the amount of $90 thousand was accrued at December 31, 2014 and recorded as an other liability. On January 7, 2015 the liability for the restricted shares and the options was reclassified to additional paid-in-capital. The January 7, 2015 awarded grants are excluded from the tables above because including them would not properly reflect the outstanding shares at December 31, 2014.